97-24509. Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 62, Number 179 (Tuesday, September 16, 1997)]
    [Notices]
    [Page 48665]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-24509]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Obstetrics and Gynecology Devices Panel of the 
    Medical Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on October 6, 1997, 8:30 
    a.m. to 5 p.m., and October 7, 1997, 8:30 a.m. to 2 p.m.
        Location: Corporate Bldg., conference room 020B, 9200 Corporate 
    Blvd., Rockville, MD.
        Contact Person: Elisa D. Harvey, Center for Devices and 
    Radiological Health (HFZ-470), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-1180, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), Obstetrics and Gynecology Devices Panel, code 
    12524. Please call the Information Line for up-to-date information on 
    this meeting.
        Agenda: On October 6, 1997, the committee will discuss and make 
    recommendations on a premarket approval application for a thermal 
    endometrial ablation device. On October 7, 1997, the committee will 
    discuss and advise FDA on a petition for reclassification of home 
    uterine activity monitors from class III (premarket approval) to class 
    II (special controls).
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by September 29, 
    1997. Oral presentations from the public will be scheduled between 
    approximately 8:30 a.m. and 9:30 a.m. on October 6 and 7, 1997. Time 
    allotted for each presentation may be limited. Those desiring to make 
    formal oral presentations should notify the contact person before 
    September 29, 1997, and submit a brief statement of the general nature 
    of the evidence or arguments they wish to present, the names and 
    addresses of proposed participants, and an indication of the 
    approximate time required to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: September 8, 1997
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 97-24509 Filed 9-15-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
09/16/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-24509
Pages:
48665-48665 (1 pages)
PDF File:
97-24509.pdf